Trade-Ideas LLC identified

Analogic

(

ALOG

) as a strong and under the radar candidate. In addition to specific proprietary factors, Trade-Ideas identified Analogic as such a stock due to the following factors:

  • ALOG has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $12.7 million.
  • ALOG has traded 18.447800000000000864019966684281826019287109375 options contracts today.
  • ALOG is making at least a new 3-day high.
  • ALOG has a PE ratio of 21.
  • ALOG is mentioned 1.90 times per day on StockTwits.
  • ALOG has not yet been mentioned on StockTwits today.
  • ALOG is currently in the upper 20% of its 1-year range.
  • ALOG is in the upper 35% of its 20-day range.
  • ALOG is in the upper 45% of its 5-day range.
  • ALOG is currently trading above yesterday's high.

'Strong and Under the Radar' stocks tend to be worthwhile stocks to watch for a variety of factors including historical back testing and price action. Market technicians refer to such stocks as being in an accumulation phase before a mark-up and peak. Traders and hedge funds have frequently found that these types of stocks continue to build a solid price base and then ultimately spike higher and peak when others 'discover' how good the stock is performing. By leveraging the social discovery aspect of StockTwits we are highlighting stocks that don't currently receive much attention from retail investors, but we suspect may soon garner more attention.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in ALOG with the Ticky from Trade-Ideas. See the FREE profile for ALOG NOW at Trade-Ideas

More details on ALOG:

Analogic Corporation, a technology company, designs, manufactures, and sells medical imaging, ultrasound, and security systems and subsystems to original equipment manufacturers (OEMs) and end users in the healthcare and airport security markets worldwide. The stock currently has a dividend yield of 0.5%. ALOG has a PE ratio of 21. Currently there is 1 analyst that rates Analogic a buy, no analysts rate it a sell, and none rate it a hold.

The average volume for Analogic has been 101,800 shares per day over the past 30 days. Analogic has a market cap of $1.1 billion and is part of the health care sector and health services industry. The stock has a beta of 0.69 and a short float of 9.2% with 6.63 days to cover. Shares are up 1.3% year-to-date as of the close of trading on Thursday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates Analogic as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and deteriorating net income.

Highlights from the ratings report include:

  • Compared to its closing price of one year ago, ALOG's share price has jumped by 27.98%, exceeding the performance of the broader market during that same time frame. Regarding the stock's future course, our hold rating indicates that we do not recommend additional investment in this stock despite its gains in the past year.
  • ALOG's revenue growth trails the industry average of 34.3%. Since the same quarter one year prior, revenues slightly increased by 8.8%. This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share.
  • 41.46% is the gross profit margin for ANALOGIC CORP which we consider to be strong. Regardless of ALOG's high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, the net profit margin of 7.03% trails the industry average.
  • The change in net income from the same quarter one year ago has exceeded that of the S&P 500, but is less than that of the Health Care Equipment & Supplies industry average. The net income has decreased by 2.5% when compared to the same quarter one year ago, dropping from $11.15 million to $10.87 million.
  • The company's current return on equity has slightly decreased from the same quarter one year prior. This implies a minor weakness in the organization. In comparison to the other companies in the Health Care Equipment & Supplies industry and the overall market, ANALOGIC CORP's return on equity is significantly below that of the industry average and is below that of the S&P 500.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.